Gregg B. Morin
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma.
Journal: Cell reports
Published: April 10, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.
Journal: Cell reports
Published: February 19, 2026
Hepatocyte growth factor activator inhibitor-2 rapidly inactivates airway-expressed human Type II Transmembrane Serine Proteases.
Journal: The Journal of biological chemistry
Published: February 05, 2026
Attribute-Weighted Aggregation of Tandem Mass Reporter Ion Intensity for Protein Quantification Using Isobaric Labeling.
Journal: Journal of proteome research
Published: September 23, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas.
Journal: Neoplasia (New York, N.Y.)
Published: May 15, 2025
Protocol for plasma membrane enrichment by ultracentrifugation for mass spectrometry of cell lines, xenografts, and patient tumors.
Journal: STAR protocols
Published: May 14, 2025
Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.
Journal: Nature communications
Published: February 21, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.
Journal: The Journal of pathology
Published: January 26, 2025
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis.
Journal: Communications biology
Published: December 03, 2024
Structural basis of TMPRSS11D specificity and autocleavage activation.
Journal: Nature communications
Published: October 30, 2024
Last Updated: 09/26/2026